HRT FINANCIAL LP

Position in DHR — Danaher Corp /De/

CIK 1475597 NEW YORK, NY

Position in DHR

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$33,688,696

+$11,688,569 QoQ

Shares Held

177,683

+84.9% QoQ

Ownership

0.025%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

HRT FINANCIAL LP holds $56,167,229 across 14 Diagnostics & Research names. DHR ranks #1 (60.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	DHR	Danaher Corp /De/ This page	177,683	$33,688,696
2	MYGN	Myriad Genetics Inc	1,786,319	$8,038,435
3	MEDP	Medpace Holdings, Inc.	7,571	$3,635,518
4	QGEN	Qiagen N.V.	72,302	$2,894,972
5	SHC	Sotera Health Co	139,192	$1,996,013
6	ADPT	Adaptive Biotechnologies Corp	131,241	$1,821,625
7	PSNL	Personalis, Inc.	208,891	$1,330,635
8	VCYT	Veracyte, Inc.	31,312	$1,008,559

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$33,688,696	177,683	+84.9%	Shares	Defined	2026-05-14
2025-12-31	$22,000,127	96,104	+196.0%	Shares	Defined	2026-02-12
2025-09-30	$6,437,105	32,468	+1.6%	Shares	Defined	2025-11-14
2025-06-30	$6,310,415	31,945	+13.6%	Shares	Defined	2025-08-14
2025-03-31	$5,764,600	28,120	-87.3%	Shares	Defined	2025-05-15
2024-09-30	$61,787,164	222,240	+164.4%	Shares	Defined	2024-11-12
2023-12-31	$19,447,828	84,066	-38.2%	Shares	Defined	2024-02-09
2023-09-30	$29,897,368	135,930	-45.4%	Shares	Defined	2023-11-13
2021-12-31	$72,567,114	248,794	+1013.9%	Shares	Defined	2022-02-14
2021-03-31	$4,456,703	22,335	+334.1%	Shares	Defined	2021-05-17
2020-12-31	$1,013,218	5,145	-78.7%	Shares	Defined	2021-02-16
2020-03-31	$2,964,648	24,161	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.